GlassScriptPhysician profile
Heather E Rothrock
NPI 1780798819
$3,353.95
in general payments reported to CMS, 2019-2025
19 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $806 · 2022: $792 · 2023: $811 · 2024: $555 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $706.87 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $665.84 | 2021-2025 | |
| Pfizer INC. | $425.65 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $245.48 | 2021-2025 | Verquvo |
| Medtronic, INC. | $237.39 | 2021-2024 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Astrazeneca Pharmaceuticals LP | $151.00 | 2021-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $122.72 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $121.75 | 2021-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $114.14 | 2021 | |
| Novo Nordisk INC | $97.43 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $97.42 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.99 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.17 | 2022 | |
| Esperion Therapeutics, INC. | $58.60 | 2021-2023 | Nexletol |
| Alnylam Pharmaceuticals INC. | $54.57 | 2025 | Amvuttra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $44.63 | 2024 | Amplatzer Amulet |
| Janssen Pharmaceuticals, INC | $27.44 | 2022 | |
| Baxter Healthcare | $20.65 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $14.21 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rothrock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.